Praxis Pharmaceutical participates in the research, development, production and marketing of innovative drugs, offering new solutions for less common serious diseases.
The main drugs investigated and marketed by Praxis Pharmaceutical are targeted at minority patient population groups, rare diseases, cancer treatment, etc.
To this effect, and in order to offer these new products and therapies to the patients that need them, Praxis Pharmaceutical focuses much of its effort on creating alliances with foreign companies that investigate or market new products in other countries, and which are interested in marketing them in Spain, Portugal, France or South America.
From our department for the development of new opportunities, we are on the constant search for new drugs that have been investigated or marketed in any country, in order to offer them to the medical profession in Spain, Portugal, France or South America.
Praxis Pharmaceutical seeks both companies that can offer licenses for their products in Spain, Portugal and South America, and foreign companies that wish to start their production in Spain.
info@praxisph.com